News

Filter

Current filters:

Mentax

1 to 9 of 10 results

Glenmark pretax profits rise 54%

04-02-2002

India's Glenmark Pharmaceuticals has posted a 47% sales increase for thethird quarter ended December…

ButenafineCefdinirLinezolidMentaxOmnicefZyvox

Efficacy With Penederm's Mentax

03-03-1997

Positive efficacy results with Penederm's antifungal agent Mentax(butenafine hydrochloride 1%) have been…

ButenafineMentaxSchering PloughSchering-Plough

Penederm Signs Dermatological Product Deal With Merck Unit

03-02-1997

- Penederm Inc has signed an agreement with Merck KGaA-owned CenterLaboratories for the co-promotion…

BenzamycinButenafineClocortoloneClodermEmgelErythromycinIlotycinMentaxMerck KGaA

Additional Indications For Mentax In USA

13-01-1997

Developed by Kaken Pharmaceutical of Japan, the topical antifungalMentax (1% butenafine hydrochloride…

ButenafineMentaxSchering PloughSchering-Plough

Penederm's Mentax Approvable, Says FDA

15-04-1996

- Penederm has received an approvable letter from the US Food and Drug Administration for Mentax (butenafine...

ButenafineMentax

Good Trial Results With Penederm Antifungal

26-02-1996

Kaken Pharmaceutical's butenafine hydrochloride (benzylamine KP-363), a proprietary prescription antifungal…

ButenafineMentaxSchering PloughSchering-Plough

Penederm /UCB agreement for antifungal KP363

29-01-1996

- Penederm has signed a licensing agreement with Belgium's UCB, giving an unnamed UCB subsidiary rights…

ButenafineMentaxUCB

1 to 9 of 10 results

COMPANY SPOTLIGHT

Menarini

Back to top